Sign in

CIK 0001894562 · <br>Emerging growth company

Prime Medicine, Inc.

Sign in to watch
Ticker
PRME
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-465-0013
Business address
60 FIRST ST., CAMBRIDGE, MA, 02141
  1. 144 Insider Sale of Securities
  2. 4 Planned sale 10% owner sold 31,061 shares at an average $13.45 ($417,893)
  3. 4 Planned sale 10% owner sold 131,861 shares at an average $14.33 ($1,889,739)
  4. 4 Planned sale 10% owner sold 90,310 shares at an average $13.62 ($1,230,338)
  5. 144 Insider Sale of Securities
  6. 4 Planned sale 10% owner sold 65,649 shares at an average $12.63 ($829,275)
  7. 8-K Event Regulation FD disclosure
  8. 4 Planned sale 10% owner sold 185,242 shares at an average $12.74 ($2,359,309)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Planned sale 10% owner sold 114,023 shares at an average $13.82 ($1,575,337)
  12. 10-Q Report Quarterly Report
  13. DEFA14A Proxy Proxy Materials
  14. 8-K Event Executive or director change
  15. 8-K Event Results of operations
  16. 4 Planned sale 10% owner sold 422,010 shares at an average $14.09 ($5,946,340)
  17. 144 Insider Sale of Securities
  18. ARS Other Annual Report to Security Holders
  19. DEFA14A Proxy Proxy Materials
  20. DEF 14A Proxy Proxy Statement

Page 11 of 16 · 302 filings